Delivery Order SPE2DB24D2101-SPE2DB26FKFCH
Award Date 10/23/25
Potential Completion Date 10/24/25
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 15, 2025, for Prolia 60 mg/mL syringes valued at $12,957.22. The contract employs firm fixed pricing with an ultimate completion date of September 16, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $59,815.89 by the Defense Logistics Agency (DLA) on September 22, 2025. The contract, designated as a firm fixed-price delivery order with no set-aside, calls for the supply of Prolia 60 mg/mL syringes and is scheduled for completion by September 23, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,746.68 for Prolia 60 mg/ml syringes on June 25, 2025, with an ultimate completion date of June 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $14,887.74 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prolia 60 mg/ml syringes. This non-set-aside, firm fixed price contract is scheduled for completion by August 20, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $19,857.04 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with a firm fixed price contract type and ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for PROLIA 60 mg/mL syringes valued at $13,150.17 by the Defense Logistics Agency on September 16, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a non-competitive award issued under an existing contract vehicle. The award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and fulfills...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,601.60 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Prolia 60 mg/ml syringes. The contract is not set-aside and operates under a firm fixed-price delivery order model, with performance to be completed by July 15, 2025, at the vendor's Conshohocken, Pennsylvania facility. This award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,350.56 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the prime contractor. The contract represents a call against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion...
- The Defense Logistics Agency awarded a $21,429 delivery order to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes, with an ultimate completion date of September 25, 2025. This contract employs firm fixed price terms under a non-competitive, non-set-aside arrangement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $33,324.63 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...